Surmodics | SRDX - Pre Tax Profit


Surmodics reported $-5.9M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Align Technology USD 148.89M 27.71M Mar/2026
Anika Therapeutics USD 764K 3M Dec/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Artivion USD 11.4M 7.84M Dec/2025
Baxter International USD -756M 877M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
EDAP TMS EUR -4.91M 597K Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Haemonetics USD 59.97M 8.69M Dec/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Merit Medical Systems USD 51.06M 22.12M Dec/2025
Mesa Laboratories USD -2.22M 6.03M Dec/2024
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Option Care Health USD 81.52M 12.55M Dec/2025
Stryker USD 1.7B 676M Dec/2025
Surmodics USD -5.9M 1.61M Jun/2025
Trinity Biotech USD -5.06M 10.74M Sep/2025